ArticleJournal of nanobiotechnology2026
hUC-MSC-exosomes deliver Let-7b/7f-5p to dermal papilla cells for a multi-target synergistic treatment of androgenetic alopecia.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExosomes play pivotal roles in immunomodulation, tissue regeneration, and the treatment of diseases. However, their specific mechanisms of action remain unclear. Therefore, this study aimed to elucidate the therapeutic mechanisms of human umbilical cord mesenchymal stem cell-derived exosomes (hUC-MSC-exosomes) in androgenic alopecia (AGA). We established a modified AGA mouse model and found that hUC-MSC-Exosomes could be taken up by dermal papilla cells (DPCs), promoted the transition of hair follicles from telogen to anagen, ameliorated hair follicle miniaturization, and enhanced hair regeneration and thickening.
resultsCytological experiments revealed that exosomes inhibited aging and apoptosis of DPCs, promoted their proliferation and migration, increased alkaline phosphatase (ALP) levels, stimulated the secretion of paracrine cytokines, and reduced the expression level of the androgen receptor (AR). Exosomal miRNA sequencing analysis revealed that the top 10 miRNAs were primarily from the Let-7 family. GO and Reactome functional enrichment analyses and dual-luciferase reporter experiments revealed that hUC-MSC-exosomes delivered Let-7b-5p to target the deubiquitinating enzyme USP12, thereby inhibiting AR deubiquitination and promoting AR ubiquitination and degradation. This process further activates the Wnt/β-catenin pathway and suppresses the TGF-β/Smad pathway.
conclusionsIn summary, this study provides insights into the underlying mechanisms of action of hUC-MSC-exosomes in AGA, indicating their therapeutic potential. In-depth analysis revealed that Let-7b-5p simultaneously targets DKK3 to activate the Wnt/β-catenin pathway in multiple dimensions. Moreover, hUC-MSC-exosomes delivered Let-7f-5p to target Smad2, synergizing with Let-7b to inhibit the TGF-β/Smad pathway and suppress DHT-induced DPC apoptosis. Further exploratory clinical trial showed that hUC-MSC-exosomes increased hair density and average hair diameter in patients with AGA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.